Twenty years is a long time. That is how long the US had gone without adding a new active sunscreen ingredient. Today. That changes.
The FDA approved bemotrizinol. It joins the list of permitted filters. This isn’t just a minor tweak. It’s a shift. American sunscreen is catching up. Slowly. But it’s catching up to what Europe has been using for decades.
You probably think US sunscreens are the same as the rest of the world. They’re not. Not even close.
Currently available sunscreen filters do a poor job at protecting against long-wave UVA rays.
— Joshua Zeichner, MD
Here is the reality check. Only two ingredients are currently recognized as “Generally Recognized As Safe and Effective” (GRASE). Those are minerals: zinc oxide and titanium dioxide. Chemical filters like oxybenzone? They’re under review. Safe? Maybe. Dangerous? The jury is out.
Bemotrizinol avoids that limbo. Low absorption. It falls under the GRASE category. It’s safe. It works.
Why experts are actually excited
Most new skincare feels like marketing. This feels different. Dermatologists aren’t just tolerating it. They are pushing it.
Dr. Joshua Zeichner sees a major advantage. Bemotrizinol blocks long-wave UVA rays better than anything else currently allowed. These are the rays that dive deep into the skin. The ones linked to cancer. Most chemical filters fail here. This one succeeds.
And it doesn’t break.
Photostable. That is the word you want to hear. Ife J. Rodney points it out immediately. Other filters degrade in sunlight. They lose potency. Bemotrizinol holds up. Last longer. Stay on your face. You still need to reapply, obviously. But at least the product isn’t giving up halfway through the afternoon.
Is there anything it won’t do? Probably irritate your skin. No.
It is gentle. Sensitive skin types, take note. Dr. Rodney calls it a win for anyone who burns at the slightest provocation from other sunscreens.
There is chemistry at play, too. Gary Goldenberg notes that bemotrizinol “plays well with others.” It boosts SPF without needing huge doses. It integrates. It helps other filters do their jobs better.
“We have been stuck in the past,” Goldenberg says. And he isn’t wrong. While Europe used lightweight, advanced formulas, US shelves held outdated tech. Now? That’s shifting.
What’s in a name?
When you see bottles hitting shelves soon, don’t be confused. You won’t always see “bemotrizinol” right away.
You’ll see Parsol Shield first. That is the trade name from dsm-firmenich, the ingredient supplier. Later, regulations catch up. The generic name bemotrizinol (or BEMT ) will appear on the INCI lists.
Check your label. Keep your eyes peeled.
When can you buy it?
Not tomorrow. Maybe not even this week.
Manufacturers aren’t sitting still, though. They have been preparing for this moment. Formulations are being tweaked. Pipes are greasing.
Neutrogena is leading the charge. Kenvue, their parent company, is integrating bemotrizinol into their innovation pipeline immediately after the order finalizes later this year. They plan to use its gentleness. They plan to lean into its aesthetic benefits.
Dr. Zeichner won’t wait. “I will be the first in line.”
The FDA commissioner, Marty Makary, framed it simply: Americans deserve access. Timely. Safe. Effective.
So you wait. For a better block. For fewer irritations. For a little more peace of mind against melanoma.
In the meantime. Put on what you have. Reapply. Shade your eyes.
